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Abstract
Background: Cell lines from Atlantic salmon kidney have made it possible to culture and study infectious salmon
anemia virus (ISAV), an aquatic orthomyxovirus affecting farmed Atlantic salmon. However, transfection of these
cells using calcium phosphate precipitation or lipid-based reagents shows very low transfection efficiency. The
Amaxa Nucleofector technology™ is an electroporation technique that has been shown to be efficient for gene
transfer into primary cells and hard to transfect cell lines.
Findings: Here we demonstrate, enhanced transfection of the head kidney cell line, TO, from Atlantic salmon
using nucleofection and subsequent flow cytometry. Depending on the plasmid promoter, TO cells could be
transfected transiently with an efficiency ranging from 11.6% to 90.8% with good viability, using Amaxa’s cell line
nucleofector solution T and program T-20. A kill curve was performed to investigate the most potent antibiotic for
selection of transformed cells, and we found that blasticidin and puromycin were the most efficient for selection of
TO cells.
Conclusions: The results show that nucleofection is an efficient way of gene transfer into Atlantic salmon cells and
that stably transfected cells can be selected with blasticidin or puromycin.
Findings
Introduction of nucleic acids into cells by non-viral
methods, transfection, has been an important tool in
many aspects of cell and molecular biology since its
introduction more than 30 years ago [1,2]. Transfection
of cells with plasmids encoding a gene of interest
coupled to a reporter gene, e.g. green fluorescent pro-
tein (GFP) has become a pivotal technique for the study
of gene expression, protein trafficking and localization
[3]. Since these pioneering studies, generation of pure
plasmid DNA has become a routine task and other
methods for introduction and expression of foreign
nucleic acids in cells have been developed. These meth-
ods have later been optimized mainly for use with mam-
malian cell lines, and with the right combination of cell
type and method, almost 100% transfection efficiency
can be achieved [4]. However, when applying the same
methods to cells from other vertebrates like fish cul-
tured at lower temperatures (5-15°C), the efficiency is
often below 10% [5-7]. For analysis of the expressed
gene product by microscopy this can be sufficient, but
for biochemical studies or applications like siRNA, a
higher transfection efficiency is desired. When plasmids
are introduced for the purpose of generating recombi-
nant viruses, high transfection efficiency is also critical
for successful rescue. Cell lines from various fish species
have been successfully used for both stable transfection
and rescue of recombinant viruses [8,9]. In two papers,
promoter optimization and selection of stable cell lines
from crucian carp was reported [6,10]. Others have
reported generation of enhanced green fluorescent pro-
tein (EGFP) or MX expressing cell lines (CHSE 214)
from Chinook salmon [11,12]. In addition there are sev-
eral reports on successful expression of viral glycopro-
teins (DNA vaccination) in fish, in vivo [13]. However,
although transgenes have been transiently expressed in
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Atlantic salmon cells both in vivo [14] and in vitro
[15,16], the generation of stably expressing cell lines has
not been reported for cells from Atlantic salmon. Given
the importance of this species in fish research and aqua-
culture we have investigated methods for transfection,
expression and selection of transformed cells from this
species. Here we describe a transfection method for
Atlantic salmon cell lines using the Nucleofector tech-
nology. The principle of nucleofection is that a combi-
nation of electrical parameters and cell-type specific
nucleofection solutions ensures efficient delivery of
DNA to the nucleus, combined with low toxicity and
high cell viability. We have used 3 different cell lines
from Atlantic salmon: SHK-1, TO and ASK. They all
originate from long term cultures of head kidney cells
(mainly leucocytes) but show different expression pro-
files [17] and vary in their ability to propagate and diag-
nose infectious salmon anemia virus [18,19].
Amaxa electroporation
The methods used are described in additional file 1.
After testing the calcium phosphate transfection method
and several commercially available lipid based formula-
tions for transfection of salmon kidney cells without
ever exceeding 10% efficiency, we decided to evaluate
electroporation as an alternative. As our main long-term
goal was to establish stably transfected cell lines from
Atlantic salmon we first employed the pFRT plasmid
containing Flp recombination target sequences that
allow subsequent integration of the gene of interest
using the Flp-In vector systems. To assess the potential
transfection efficiency of salmonid cell lines, the pFRT-
GFP-Zeo plasmid was transfected into TO cells by elec-
troporation using a range of buffers and programs.
Three different buffers in combination with eight differ-
ent settings (electric pulse programs) were tested. This
optimization kit contains enough material for one round
of transfections. Directly after transfection, cell viability
was assessed by trypan blue exclusion assay. Viability
ranged from 72 to 100% with lowest mortality using
buffer T (9%, not shown). Figure 1 and 2 (respectively)
display cell viability (light diffraction) and EGFP expres-
sion (fluorescence) 3 days later. A combination of buffer
T with pulse program 20 or 27 was optimal for both
cell integrity and frequency of GFP expression (no sig-
nificant difference). As pulse program T-20 gave higher
viability directly after transfection, we used this program
in subsequent experiments.
Effect of plasmid concentration
Based on published reports [20,21] and own experience
during the course of the project, we learned that CMV
was the most efficient promoter to drive expression of a
plasmid in fish cells. In subsequent experiments we
therefore used plasmids with this promoter. As plasmid
concentration is important for obtaining high transfec-
tion efficiency, we wanted to determine the plasmid
concentration that would give the highest transfection
efficiency. Concentrations from 2.5-10 μg of the
pmaxFP-Green plasmid was transfected into ASK and
TO cells by electroporation using the buffer T and pro-
gram T-20. Maximal transfection efficiency was achieved
after 48 h and remained stable for at least one week. In
ASK cells, frequency could be increased from about 40
to 50% by increasing DNA concentration from 2.5 μg to
5 or 10 μg, whereas in TO cells maximal transfection
was achieved with 2.5 μg DNA.
Sensitivity to antibiotics
In order to determine the efficiency of selection media
on TO and SHK-1, cell cultures were treated with the
six different antibiotics most commonly used for selec-
tion of eukaryotic cells. Results shown in Figure 3a
(SHK-1) and b (TO) shows that the salmon cell lines
are most sensitive to puromycin and blasticidin. These
drugs were effectively killing salmon cells at concentra-
tions above 0.01 mg/ml whereas the other antibiotics
tested were only effective above 0.5-1 mg/ml or inactive.
Therefore, blasticidin and puromycin are probably well-
suited antibiotics for rapid selection of stable cell lines
from Atlantic salmon. A suitable vector expressing blas-
ticidin resistance, pSELECT-blasti-mcs, was therefore
chosen for stable transfection studies.
Blasticidin resistant and GFP-expressing cells were
obtained by transfection with the pSELECT-blasti-mcs
plasmid followed by selection. In cultures not selected
with blasticidin, the culture was dominated by cells not
expressing GFP (Figure 4, upper panel). In cultures
selected for 3 weeks with 0.05 mg/ml blasticidin, many
cells were GFP positive, but poor growth was observed
(Figure 4, middle panel). However, in cultures where
selective medium was replaced with normal medium for
one week, growth was restored and the fraction of GFP
positive cells was further increased (Figure 4, lower
panel). When cells were selected with 0.01 mg/ml blasti-
cidin, a lower fraction of GFP positive cells were
observed (not shown).
Discussion
The ability to express endogenous or foreign proteins in
cell cultures has made an important impact in modern
experimental biology. This technique is used to investigate
protein localization and function in health and disease.
Expression of mutant proteins has greatly facilitated the
understanding of many heritable human diseases. In virol-
ogy, the ability to express viral proteins one by one in the
absence of infection has been important for the dissection
of their functions during the replication cycle. This
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method has not been exploited fully in the study of marine
viruses, partly because of rather inefficient means to intro-
duce and express the plasmids in cells from marine organ-
isms, often cultured at low temperatures. We have
therefore investigated various transfection methods using
salmon cell lines grown at 20°C. In this report we have
shown that, the nucleofector technology can be used to
increase transfection efficiency up to 90%, depending on
cell type. This is a significant improvement compared to
our own experience with transfection of fish cells and pub-
lished reports using other methods [5,6,22,23]. In contrast
to lipid-based transfection, where DNA is transferred into
the cytoplasm and can only enter the nucleus during mito-
sis, when the nuclear envelope is disintegrated,
Figure 1 Cell viability and transfection efficiency after nucleofection of TO cells. A total of 5 × 106 cells were transfected with 5 μg pFRT/
lacZeo Flp, using buffer R, T or V, and a range of programs. Three days after transfection, cell viability (a) and GFP expression (b) was quantified
by flow cytometry. * = Electroporation, no plasmid ** = Plasmid, no electroporation program. Data from a representative experiment (out of 3) is
depicted here.
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nucleofection is supposed to deliver DNA into the nucleus
independent of cell cycle. High gene expression is depen-
dent on the efficiency of the promoter under which the
gene of interest is expressed. Even though the SV40
(Simian virus 40) promoter has not been shown to be effi-
cient in fish cells [24], we wanted to use the Flp-In system
to create a stable host cell line, as this would ease later
introduction of genes of interest. However, it was not pos-
sible to obtain good transfection efficiency, probably due
to a suboptimal promoter. The vector has zeocin resis-
tance, and as our study shows, zeocin is not a potent drug
for killing of untransfected Atlantic salmon cells. In the
present study we also present data on how to successfully
perform selection in Atlantic salmon cell culture. For
selection purposes, the promoter driving the expression of
the antibiotic resistant marker is also important. When
using the vector pSELECT-blasti-mcs, with blasticidin
resistance driven by the CMV promoter and the hEF1-
HTLV promoter in front of GFP, we were able to obtain
cell culture consisting of blasticidin-resistant, GFP positive
cells. Compared to antibiotics traditionally used for effi-
cient selection in mammalian systems, we show that
blasticidin is a potent antibiotic for selection in cell lines
from Atlantic salmon. Blasticidin is reported as a potent
antibiotic in mammalian cell lines [25]. It works by inhibit-
ing amino acid incorporation into polypeptides. Use of
blasticidin or puromycin can significantly increase success
in establishing stable cell lines. Evidently, of the antibiotics
tested here, nucleoside antibiotics seem to kill non-resis-
tant cells most efficiently. Another aspect concerning
selection for stable cell lines is the amount of antibiotics
used. Using an antibiotic causing rapid death of non-resis-
tant cells at low concentrations is cost-efficient. Stable fish
cell lines from other species have been reported
[10,12,26,27] and further studies are in progress to estab-
lish stable cell lines from Atlantic salmon.
Establishing a protocol for transfection, we also looked
into the effect of the amount of DNA on transfection
efficiency. The results indicate that the protocol is opti-
mized for TO cells, as varying the amount of DNA has
little effect on transfection efficiency. For ASK cells, the
transfection efficiency increases when plasmid DNA
concentration is increased from 2.5 - 5 μg. Increasing
the amount of DNA from 5 - 10 μg, did not seem to
Figure 2 Effect of DNA concentration on nucleofection frequency. GFP expression was analyzed by flow cytometry 48, 72, 96 and 168h after
transfection of TO or ASK cells with varying amounts (2.5, 5 or 10 μg) of pmaxFP-Green-N. Data from a representative experiment (out of 3) is
depicted here.
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have an effect. The much lower efficiency observed for
ASK cells, indicates that further optimization, e.g. with
nucleofection- buffer or program, is needed to increase
transfection efficiency.
There are many reports on successful nucleofection of
mammalian primary cells and cell lines, and also a
report on successful nucleofection of primary zebrafish
fibroblasts [28]. Our findings have been communicated
in meetings and been implemented by other groups
[15,16,29]. The transfection efficiency reported here is
sufficient for biochemical studies and will hopefully also
be an important contribution to the regeneration of
virus from plasmids (reverse genetics) or studies invol-
ving siRNA in Atlantic salmon cell lines. Although not
tested here, there are reasons to believe that plasmid
size will affect transfection efficiency. In a study by
Figure 3 Antibiotic sensitivity curve for SHK-1 (a) and TO (b) cells. Cells were seeded at a density of 25 000 cells/well and incubated with a
range of concentrations of the antibiotics tested. After two weeks, cell viability was measured using the cyquant cell proliferation assay. Data
were normalized to cells in normal medium (100% viability) and expressed as mean of 3 experiments ± SE.
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Kreiss et al, it was demonstrated that a 2.9 kb plasmid
containing a luciferase gene was expressed between 6
and 77 times higher than a 52.5 kb plasmid containing
the same gene, dependent on cell type [30]. The plas-
mids used here were between 3.9 kb and 5.7 kb and
therefore in the lower range.
Conclusions
In summary, we demonstrate improved transfection of
cell lines from Atlantic salmon using nucleofection; we
also propose a method for selection of transfected cells
in selective medium containing blasticidin. This is of
immediate interest for studies involving transient trans-
fection of the cell lines used and may be of importance
for future establishment of foreign or recombinant pro-
tein-expressing cell lines from Atlantic salmon.
Additional material
Additional file 1: Supplementary methods. The materials and
methods from this study
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Phase contrast GFP positive cells
Figure 4 Phase contrast and fluorescent micrographs (40X objective) of GFP positive TO cells after growth in normal medium (upper
panels) and after constant selection with 0.05 mg/ml blasticidin (middle panels) or after selection with 0.05 mg/ml blasticidin for 2
weeks and then normal medium for 1 week (lower panels). Scale bar = 50 um.
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